Cargando…
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
OBJECTIVES: One-fifth of Covid-19 patients suffer a severe course of Covid-19 infection; however, the specific causes remain unclear. Mast cells (MCs) are activated by SARS-CoV-2. Although only recently recognized, MC activation syndrome (MCAS), usually due to acquired MC clonality, is a chronic mul...
Autores principales: | Afrin, Lawrence B., Weinstock, Leonard B., Molderings, Gerhard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529115/ https://www.ncbi.nlm.nih.gov/pubmed/32920235 http://dx.doi.org/10.1016/j.ijid.2020.09.016 |
Ejemplares similares
-
Mast cell activation symptoms are prevalent in Long-COVID
por: Weinstock, Leonard B., et al.
Publicado: (2021) -
A survey of the currently known mast cell mediators with potential relevance for therapy of mast cell-induced symptoms
por: Molderings, Gerhard J., et al.
Publicado: (2023) -
Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
por: Afrin, Lawrence B., et al.
Publicado: (2022) -
Mast cell deposition and activation may be a new explanation for epiploic appendagitis
por: Weinstock, Leonard B., et al.
Publicado: (2018) -
Efficacy and toxicity of hydroxyurea in mast cell activation syndrome patients refractory to standard medical therapy: retrospective case series
por: Weinstock, Leonard B., et al.
Publicado: (2022)